Earlier Patient Access – the UK Early Access to Medicines Scheme (EAMS)
The Early Access to Medicines Scheme (EAMS) was launched in the UK in April 2014 following a public consultation and government response, which outlined the scope of a potential scheme. The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for two pivotal milestone decisions...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-01-01
|
| Series: | Medicine Access @ Point of Care |
| Online Access: | https://doi.org/10.5301/maapoc.0000009 |